קופגוס

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

RIBAVIRIN 200 MG

제공처:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC 코드:

J05AB04

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

HOFFMANN LA ROCHE, SWITZERLAND

치료 그룹:

RIBAVIRIN

치료 징후:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

승인 날짜:

2013-04-01